Evidence map›Paper›PMID 35594856›Full record

ArticleMolecular cell2022

Human NLRP1 is a sensor of pathogenic coronavirus 3CL proteases in lung epithelial cells.

Rémi Planès, Miriam Pinilla, Karin Santoni, Audrey Hessel, Charlotte Passemar, Kenneth Lay, Perrine Paillette, Ana-Luiza Chaves Valadão, Kim Samirah Robinson, Paul Bastard and 26 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed, 1 pooled it
11.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 1 synthesis or guideline pooled it, 139 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. NINJ1: implications for plasma membrane rupture and disease.Biochemical Society transactions · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Microbiology spectrum · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Human non-canonical inflammasomes activate CASP3 to limit intracellularbioRxiv : the preprint server for biology · 2025
    Article
  20. Article

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors at 10 institutions in 7 countries.

Rémi PlanèsInstitute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France; InvivoGen, Toulouse, France; IRIM, University of Montpellier, CNRS, Montpellier, France. Electronic address: remi.planes@ipbs.fr.
Miriam PinillaInstitute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France; InvivoGen, Toulouse, France.
Karin SantoniInstitute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France.
Audrey HesselInstitute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France.
Charlotte PassemarMolecular Immunity Unit, University of Cambridge Department of Medicine, MRC-Laboratory of Molecular Biology, Cambridge, UK.
Kenneth LayInstitute of Medical Biology, Agency of Science, Technology and Research, 8A Biomedical Grove, #06-06 Immunos, 138648 Singapore, Singapore; Laboratory of Human Genetics and Therapeutics, Genome Institute of Singapore (GIS), A(∗)STAR, Singapore, Singapore.
Perrine PailletteInvivoGen, Toulouse, France.
Ana-Luiza Chaves ValadãoIRIM, University of Montpellier, CNRS, Montpellier, France.
Kim Samirah RobinsonA(∗)STAR Skin Research Laboratories, 11 Mandalay Road, 308232 Singapore, Singapore.
Paul BastardLaboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, Necker Hospital for Sick Children, Paris, France; University of Paris, Imagine Institute, Paris, France; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
Nathaniel LamUniversity of Cambridge, Department of Veterinary Medicine, Cambridge CB30ES, UK; University of Cambridge, School of Clinical Medicine, Box 111, Cambridge Biomedical Campus, Cambridge CB2 0SP, UK.
Ricardo FadriqueBiological and Soft Systems, Cavendish Laboratory, University of Cambridge, JJ Thomson Avenue, Cambridge CB3 0HE, UK.
Ida RossiInstitute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France.
David PericatInstitute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France.
Salimata BagayokoInstitute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France.
Stephen Adonai Leon-IcazaInstitute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France.
Yoann RomboutsInstitute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France.
Eric PerouzelInvivoGen, Toulouse, France.
Michèle TirabyInvivoGen, Toulouse, France.
COVID Human Genetic Effort
Qian ZhangUniversity of Paris, Imagine Institute, Paris, France.
Pietro CicutaBiological and Soft Systems, Cavendish Laboratory, University of Cambridge, JJ Thomson Avenue, Cambridge CB3 0HE, UK.
Emmanuelle JouanguyLaboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, Necker Hospital for Sick Children, Paris, France; University of Paris, Imagine Institute, Paris, France; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
Olivier NeyrollesInstitute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France.
Clare E BryantUniversity of Cambridge, Department of Veterinary Medicine, Cambridge CB30ES, UK; University of Cambridge, School of Clinical Medicine, Box 111, Cambridge Biomedical Campus, Cambridge CB2 0SP, UK.
Andres R FlotoMolecular Immunity Unit, University of Cambridge Department of Medicine, MRC-Laboratory of Molecular Biology, Cambridge, UK.
Caroline GoujonIRIM, University of Montpellier, CNRS, Montpellier, France.
Franklin Zhong LeiA(∗)STAR Skin Research Laboratories, 11 Mandalay Road, 308232 Singapore, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, 11 Mandalay Road, 308232 Singapore, Singapore; Skin Research Institute of Singapore (SRIS), 11 Mandalay Road, 308232 Singapore, Singapore.
Guillaume Martin-BlondelService des Maladies Infectieuses et Tropicales, CHU de Toulouse, Toulouse, France; Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), INSERM UMR1291 - CNRS UMR5051 - Université Toulouse III, Toulouse, France.
Stein SilvaCritical Care Unit, University Hospital of Purpan, Toulouse, France.
Jean-Laurent CasanovaLaboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, Necker Hospital for Sick Children, Paris, France; University of Paris, Imagine Institute, Paris, France; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA; Howard Hughes Medical Institute, New York, NY, USA.
Céline CougouleInstitute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France.
Bruno ReversadeInstitute of Medical Biology, Agency of Science, Technology and Research, 8A Biomedical Grove, #06-06 Immunos, 138648 Singapore, Singapore; Laboratory of Human Genetics and Therapeutics, Genome Institute of Singapore (GIS), A(∗)STAR, Singapore, Singapore; Institute of Molecular and Cell Biology, 61 Biopolis Drive, 138673 Singapore, Singapore; Department of Paediatrics, Yong Loo Lin School of Medicine, National University Health System, National University of Singapore, 10 Medical Drive, 117597 Singapore, Singapore; The Medical Genetics Department, Koç University School of Medicine, 34010 Istanbul, Turkey.
Julien MarcouxInstitute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France.
Emmanuel RavetInvivoGen, Toulouse, France.
Etienne MeunierInstitute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France. Electronic address: etienne.meunier@ipbs.fr.
Centre National de la Recherche Scientifique · FRInvivoGen (France) · FRUniversity of Cambridge · GBAgency for Science, Technology and Research · SGInstitute of Human Genetics · PLMRC Laboratory of Molecular Biology · GBHôpital Purpan · FRHoward Hughes Medical Institute · USKoç University · TRUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammation observed in SARS-CoV-2-infected patients suggests that inflammasomes, proinflammatory intracellular complexes, regulate various steps of infection. Lung epithelial cells express inflammasome-forming sensors and constitute the primary entry door of SARS-CoV-2. Here, we describe that the NLRP1 inflammasome detects SARS-CoV-2 infection in human lung epithelial cells. Specifically, human NLRP1 is cleaved at the Q333 site by multiple coronavirus 3CL proteases, which triggers inflammasome assembly and cell death and limits the production of infectious viral particles. Analysis of NLRP1-associated pathways unveils that 3CL proteases also inactivate the pyroptosis executioner Gasdermin D (GSDMD). Subsequently, caspase-3 and GSDME promote alternative cell pyroptosis. Finally, analysis of pyroptosis markers in plasma from COVID-19 patients with characterized severe pneumonia due to autoantibodies against, or inborn errors of, type I interferons (IFNs) highlights GSDME/caspase-3 as potential markers of disease severity. Overall, our findings identify NLRP1 as a sensor of SARS-CoV-2 infection in lung epithelia.

Indexed as

Coronavirus 3C ProteasesCOVID-19Epithelial CellsInflammasomesNLR ProteinsSARS-CoV-2Caspase 3GasderminsHumansLungPeptide HydrolasesPhosphate-Binding ProteinsPore Forming Cytotoxic ProteinsPyroptosis3C-like protease, SARS coronavirusCaspase 3Coronavirus 3C ProteasesGasderminsGSDMD protein, humanInflammasomesNLRP1 protein, humanNLR ProteinsPeptide HydrolasesPhosphate-Binding ProteinsPore Forming Cytotoxic Proteins3CL proteasesepithelial cellsGasderminsNLRP1 inflammasomepyroptosisSARS-CoV-2

Identifiers

PMID35594856
PMCPMC9108100
OpenAlexW4280653460

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.